GSKGSK PLC-SPON ADR
CUSIP 37733W204 · depositary receipt
9 tracked investors held GSK PLC-SPON ADR (GSK) at the end of Q3 2026, worth $5.2B in total. The largest holder was Dodge & Cox, with 1.1% of its portfolio. Sarah Ketterer sold out of its position this quarter.
Holders · Q3 2026
9
New holders
0
Value held
$5.2B
Quarter-end price (est.)
$48.17
Investors holding GSK · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Dodge & Cox Dodge & Cox | 1.12% | 43,183,117 | $2.1B | REDUCE-10.4% |
| Ken Fisher Fisher Asset Management, LLC | 0.49% | 35,351,693 | $1.7B | REDUCE-1.0% |
| PRIMECAP Management PRIMECAP Management Co | 0.75% | 25,192,138 | $1.2B | ADD0.0% |
| Jeremy Grantham Grantham, Mayo, Van Otterloo & Co. LLC | 0.40% | 3,917,951 | $188.7M | ADD+8.8% |
| Kahn Brothers Group Kahn Brothers Group Inc | 0.91% | 113,552 | $5.5M | REDUCE-28.3% |
| Hillman Capital Management Hillman Capital Management, Inc. | 3.31% | 91,962 | $4.4M | REDUCE-0.5% |
| Tweedy Browne Tweedy, Browne Co LLC | 0.30% | 77,439 | $3.7M | REDUCE-5.0% |
| Richard Pzena Pzena Investment Management LLC | 0.00% | 28,964 | $1.4M | ADD+18.2% |
| Murray Stahl Horizon Kinetics Asset Management LLC | 0.01% | 23,000 | $1.1M | REDUCE-4.3% |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Sarah Ketterer | 0.00% | 7,163 | $375.5K | EXIT |